AXS Investments’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,585
Closed -$162K 461
2023
Q1
$162K Buy
2,585
+1,454
+129% +$90.8K 0.05% 226
2022
Q4
$70.8K Buy
+1,131
New +$64.9K 0.03% 259

Other funds holding PBH

AXS Investments's PBH Position: Q2 2023 in Review

AXS Investments sold out of Prestige Consumer Healthcare (PBH) in Q2 2023, closing a stake of 2,585 shares — an estimated $162K sold.

AXS Investments first reported a position in PBH in Q4 2022 and held it in 2 quarters. The position peaked at $162K in Q1 2023. 279 funds tracked by Wall St. Rank hold PBH as of Q2 2023.

  • AXS Investments reported no remaining Prestige Consumer Healthcare position as of Q2 2023 after selling out during the quarter.
  • AXS Investments sold 2,585 Prestige Consumer Healthcare shares in Q2 2023, an estimated $162K.
  • AXS Investments first reported a position in Prestige Consumer Healthcare in Q4 2022 and held it in 2 quarters.
  • AXS Investments's Prestige Consumer Healthcare position peaked at $162K in Q1 2023.
  • 279 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2023.

Based on AXS Investments's 13F filing for Q2 2023, filed 10 Aug 2023.